BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18508187)

  • 1. Fetal-maternal microchimerism in normal parous females and parous female cancer patients.
    Gilmore GL; Haq B; Shadduck RK; Jasthy SL; Lister J
    Exp Hematol; 2008 Sep; 36(9):1073-7. PubMed ID: 18508187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microchimerism in the pathogenesis of oral lichen planus.
    Weger W; Bauer M; Odell E; Pertl B; Cerroni L; Kerl H; Jakse N; Pertl C
    Exp Dermatol; 2006 Feb; 15(2):125-9. PubMed ID: 16433684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microchimerism after induced or spontaneous abortion.
    Sato T; Fujimori K; Sato A; Ohto H
    Obstet Gynecol; 2008 Sep; 112(3):593-7. PubMed ID: 18757657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting fetal microchimerism does not interfere with forensic Y-chromosome typing.
    Klintschar M; Schwaiger P; Regauer S; Mannweiler S; Kleiber M
    Forensic Sci Int; 2004 Jan; 139(2-3):151-4. PubMed ID: 15040908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal nucleated cells in maternal peripheral blood after delivery in cases of fetomaternal hemorrhage.
    Hamada H; Arinami T; Hamaguchi H; Kubo T
    Obstet Gynecol; 1995 Mar; 85(3):449-51. PubMed ID: 7862390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal microchimerism in women with breast cancer.
    Gadi VK; Nelson JL
    Cancer Res; 2007 Oct; 67(19):9035-8. PubMed ID: 17909006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism.
    Bianchi DW; Farina A; Weber W; Delli-Bovi LC; Deriso M; Williams JM; Klinger KW
    Am J Obstet Gynecol; 2001 Mar; 184(4):703-6. PubMed ID: 11262475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male cell microchimerism in normal and diseased female livers from fetal life to adulthood.
    Guettier C; Sebagh M; Buard J; Feneux D; Ortin-Serrano M; Gigou M; Tricottet V; Reynès M; Samuel D; Féray C
    Hepatology; 2005 Jul; 42(1):35-43. PubMed ID: 15962317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates.
    Flesland O; Ip LS; Storlien AS; Spurkland A; Larsen J; Solheim BG
    Transfus Apher Sci; 2004 Dec; 31(3):173-80. PubMed ID: 15556463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of multiple loci can increase reliability of detection of fetal Y-chromosome DNA in maternal plasma.
    Wagner J; Dzijan S; Pavan-Jukić D; Wagner J; Lauc G
    Prenat Diagn; 2008 May; 28(5):412-6. PubMed ID: 18395868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of fetal-maternal microchimerism on the activated haplo-identical peripheral blood stem cell treatment for cancer.
    Yu J; Ren X; Cao S; Li H; Hao X
    Cytotherapy; 2008; 10(4):331-9. PubMed ID: 18574766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of male hematopoietic CD34+ cells in the circulation of women does not affect prenatal diagnostic techniques.
    Coata G; Picchiassi E; Centra M; Fanetti A; Maulà V; Benedetto C; Di Renzo GC
    Am J Obstet Gynecol; 2009 May; 200(5):528.e1-7. PubMed ID: 19285653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block.
    Stevens AM; Hermes HM; Lambert NC; Nelson JL; Meroni PL; Cimaz R
    Rheumatology (Oxford); 2005 Feb; 44(2):187-91. PubMed ID: 15536065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study.
    Lapierre V; Aupérin A; Robinet E; Ferrand C; Oubouzar N; Tramalloni D; Saas P; Debaene B; Lasser P; Tiberghien P
    Transfusion; 2007 Sep; 47(9):1691-9. PubMed ID: 17725736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal microchimerism and cancer.
    Gadi VK
    Cancer Lett; 2009 Apr; 276(1):8-13. PubMed ID: 18845390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.
    Lambert NC; Erickson TD; Yan Z; Pang JM; Guthrie KA; Furst DE; Nelson JL
    Arthritis Rheum; 2004 Mar; 50(3):906-14. PubMed ID: 15022334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair.
    Cirello V; Recalcati MP; Muzza M; Rossi S; Perrino M; Vicentini L; Beck-Peccoz P; Finelli P; Fugazzola L
    Cancer Res; 2008 Oct; 68(20):8482-8. PubMed ID: 18922922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues.
    Cirello V; Perrino M; Colombo C; Muzza M; Filopanti M; Vicentini L; Beck-Peccoz P; Fugazzola L
    Int J Cancer; 2010 Jun; 126(12):2874-8. PubMed ID: 19856309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feto-maternal microchimerism in connective tissue diseases.
    Gannagé M; Amoura Z; Lantz O; Piette JC; Caillat-Zucman S
    Eur J Immunol; 2002 Dec; 32(12):3405-13. PubMed ID: 12432571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of microchimerism in female patients.
    Vymetalova Y; Bohuslavova R; Hubacek JA; Dufkova B; Kocik M; Malek I; Kautzner J
    Transplant Proc; 2008 Dec; 40(10):3685-7. PubMed ID: 19100466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.